Research programme: molecular diagnostics - VECT-HORUS

Drug Profile

Research programme: molecular diagnostics - VECT-HORUS

Latest Information Update: 09 Sep 2016

Price : $50

At a glance

  • Originator VECT-HORUS
  • Class Diagnostic agents; Diagnostic conjugates; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical CNS disorders
  • Research Cancer

Most Recent Events

  • 15 Apr 2015 Research programme: molecular diagnostics - VECT-HORUS is available for licensing as of 15 Apr 2015. http://www.vect-horus.com/
  • 15 Apr 2015 Early research in Cancer (Diagnosis) in France (unspecified route)
  • 15 Apr 2015 Preclinical trials in CNS disorders (Diagnosis) in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top